4:21:07 AM PDT - Wednesday, September 30th, 2020

BioNTech wins $445 million German grant for COVID-19 vaccine  

By Editor - Tue Sep 15, 4:33 am

  • Comments Off on BioNTech wins $445 million German grant for COVID-19 vaccine

German biotech firm BioNTech said on Tuesday it had secured almost $450 million in government funding to speed up work on its COVID-19 vaccine candidate and expand its production capacity in Germany. BioNTech and partners Pfizer Inc and China’s Shanghai Fosun Pharmaceutical Group Co Ltd are among the leading developers of experimental COVID-19 vaccines, based on molecules carrying a genetic code called messenger RNA (mRNA). Mainz-based BioNTech, founded in 2008 and listed on the Nasdaq exchange last year, said it had been awarded 375 million euros ($445 million) in funding, after applying under a scheme announced in July by Research Minister Anja Karliczek.

Read this article:

BioNTech wins $445 million German grant for COVID-19 vaccine

  • Comments Off on BioNTech wins $445 million German grant for COVID-19 vaccine

Leave a Reply

Comments are closed on this post.